Y. Vázquez

发表

A recombinant BCG-based vaccine against the human respiratory syncytial virus induces a balanced cellular immune response against viral and mycobacterial antigens

P. González, N. Gálvez, A. Kalergis, 2022, medRxiv.

Interim Report: Safety And Immunogenicity Of An Inactivated Vaccine Against Sars-Cov-2 In Healthy Chilean Adults In A Phase 3 Clinical Trial

A. Sette, D. Weiskopf, P. González, 2021, medRxiv.

Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.

E. Brandan, Claudio Cabello-Verrugio, M. Morales, 2015, Clinical science.

Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2)

E. Brandan, C. Vio, D. Cabrera, 2013, Cell and Tissue Research.

Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.

E. Brandan, Claudio Cabello-Verrugio, M. Morales, 2012, The international journal of biochemistry & cell biology.

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

A. Sette, D. Weiskopf, C. Asenjo, 2022, eBioMedicine.

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern

A. Sette, D. Weiskopf, P. González, 2022, mBio.

An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile

D. Weiskopf, A. Grifoni, Reta, 2022, medRxiv.

Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection

P. González, A. Kalergis, S. Bueno, 2022, Frontiers in Cellular and Infection Microbiology.

Identification of biomarkers for disease severity in nasopharyngeal secretions of infants with upper or lower respiratory tract viral infections

A. Kalergis, S. Bueno, C. Riedel, 2022, Clinical and experimental immunology.

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial

P. González, N. Gálvez, J. Soto, 2020, EClinicalMedicine.

The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.

M. Morales, J. Ábrigo, F. Simon, 2014, Clinical science.

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

A. Sette, D. Weiskopf, D. Goldblatt, 2022, eLife.

Differential immune response induced by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial

D. Weiskopf, A. Grifoni, R. Soto-Rifo, 2022, medRxiv.

A booster dose of an inactivated vaccine increases neutralizing antibodies and T cell responses against SARS-CoV-2

A. Sette, D. Weiskopf, P. González, 2021, medRxiv.

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children

A. Sette, D. Weiskopf, P. González, 2022, mBio.

Evaluation of monoclonal antibodies that detect conserved proteins from Respiratory Syncytial Virus, Metapneumovirus and Adenovirus in human samples.

S. Bueno, C. Riedel, A. A. Beckhaus, 2018, Journal of virological methods.

Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.

A. Sette, D. Weiskopf, P. González, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

P. González, Weining Meng, N. Gálvez, 2021, Frontiers in Immunology.

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

A. Sette, D. Weiskopf, P. González, 2021, Frontiers in Immunology.

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update

P. González, S. Bueno, C. Riedel, 2019, Front. Immunol..

Interleukin-10 Produced by Myeloid-Derived Suppressor Cells Provides Protection to Carbapenem-Resistant Klebsiella pneumoniae Sequence Type 258 by Enhancing Its Clearance in the Airways

A. Prince, S. Bueno, Isidora Suazo, 2019, Infection and Immunity.

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults

P. González, N. Gálvez, A. Kalergis, 2023, Frontiers in immunology.

A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern.

A. Sette, D. Weiskopf, P. González, 2022, medRxiv : the preprint server for health sciences.

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects

P. González, A. Kalergis, S. Bueno, 2023, The Journal of infectious diseases.

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults

A. Sette, D. Weiskopf, C. Asenjo, 2023, eBioMedicine.